Research Paper Volume 15, Issue 15 pp 7616—7636
An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer
Figure 7. Tumor mutational burden (TMB) analysis of patients with breast cancer. (A) TMB analysis of patients in high-risk group and low-risk group. (B) Kaplan–Meier survival curve shows that the OS of patients with low TMB (L-TMB) is longer than that of patients with high TMB (H-TMB). (C, D) Mutational burden landscape of patients in high-risk group and low-risk group.